Quadriceps and Hamstring Activation Timing

April 9, 2026 updated by: KTO Karatay University

Quadriceps and Hamstring Activation Timing During Functional Tasks Following ACL Reconstruction

The anterior cruciate ligament (ACL) plays a crucial role in maintaining knee stability and enabling dynamic movement. ACL injuries are common, especially among athletes, and reconstruction surgery is frequently performed to restore knee function. Despite rehabilitation, neuromuscular deficits-particularly in muscle activation timing-may persist. This study will aim to evaluate the activation timing of quadriceps and hamstring muscles during a functional task in individuals who have undergone ACL reconstruction.

Study Overview

Detailed Description

This study will be conducted as a cross-sectional, quantitative investigation involving male participants who have undergone ACL reconstruction using semitendinosus and gracilis tendon grafts. Electromyographic (EMG) signals will be collected using the Noraxon Ultium EMG system and analyzed with Noraxon MyoResearch XP software. Muscle activation onset timing will be assessed for the vastus medialis oblique (VMO), vastus lateralis (VL), semimembranosus (SM), semitendinosus (ST), and biceps femoris (BF). Participants will perform a standardized single-leg squat task, during which EMG-based activation timing will be recorded. The findings are expected to provide insight into neuromuscular control strategies and inform rehabilitation approaches following ACL reconstruction.

Study Type

Observational

Enrollment (Estimated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karatay
      • Konya, Karatay, Turkey (Türkiye), 42030
        • KTO Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of male individuals aged 18-45 years who have undergone anterior cruciate ligament (ACL) reconstruction using semitendinosus and gracilis tendon grafts.

Description

Inclusion Criteria:

  • participants must be males between 18 and 45 years old
  • must have undergone ACL repair surgery and be within 6 months to 2 years post-surgery
  • should have completed a standard rehabilitation program post-surgery
  • must provide written informed consent to participate in the study
  • should be in generally good health, without any other significant medical conditions that could affect the study outcomes;
  • must have returned to a moderate level of physical activity post-surgery

Exclusion Criteria:

  • participants with any neurological disorders affecting lower limb function or any other musculoskeletal disorders or injuries that could affect the lower limb, apart from the ACL injury
  • those with cardiovascular conditions that contraindicate participation in physical activity
  • those with contraindications to kinesiological electromyography, such as skin conditions or allergies to electrodes
  • those who are unable or unwilling to comply with study procedures and follow-ups
  • those who have had multiple ACL surgeries on the same knee
  • participants involved in ongoing litigation related to their ACL injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electromyography
Time Frame: Single session (approximately 15-20 minutes per participant)
Muscle Activation Timing (%MVIC)
Single session (approximately 15-20 minutes per participant)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2026

Primary Completion (Estimated)

May 2, 2026

Study Completion (Estimated)

May 15, 2026

Study Registration Dates

First Submitted

April 9, 2026

First Submitted That Met QC Criteria

April 9, 2026

First Posted (Actual)

April 16, 2026

Study Record Updates

Last Update Posted (Actual)

April 16, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared to protect participant privacy and confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Reconstruction

Clinical Trials on Electromyography

Subscribe